DLC1基因在人脑胶质瘤组织中的表达

目的 探讨抑癌基因DLC1在人脑胶质瘤组织中的表达和功能.方法 收集广州医学院第二附属医院神经外科自2007年1月至2009年6月手术切除的胶质瘤标本39例及同期行颅脑减压术治疗的颅脑损伤患者的正常脑组织10例,实时荧光定量PCR检测DLC1 mRNA的表达;将质粒pCS2-DLC1转染体外常规培养的人胶质瘤细胞株U251,同时用空载体pCS2-MT转染作为对照组,转染后36 h应用Western blot检测DLC1表达标签蛋白Mvc,应用MTT检测U251细胞增殖能力的变化.结果实时荧光定量PCR结果显示胶质瘤组织中DLC1 mRNA表达水平高于对照组,差异有统计学意义(P=0.000),且Ⅰ级胶质瘤组织DLC1 mRNA的表达水平高于Ⅱ、Ⅲ、Ⅳ级,差异有统计学意义(平均秩次分别为44.20、30.23、32.25、31.0,H=18.818,P=0.001);Western blot检测结果显示DLC1标签蛋白Mvc在pCS2-DLCI转染组细胞呈过表达,在pCS2-MT转染组细胞无明显表达;MTT检测显示pCS2-DLC1转染组U251细胞吸光度值高于pCS2-MT转染组,差异有统计学意义(P=0.002).结论 高表达的DLC1可能促进胶质瘤的形成和发展.

Expression of DLC1 gene in human glioma tissues

Objective To investigate the expression and the role of DCL1 gene in human glioma. Methods Thirty-nine glioma samples and 10 control tissues resected from healthy brain tissue with traumatic brain injury were collected for analysis. Real-time quantitative PCR was employed to detect the DCL1 gene expression at the mRNA level. Plasmid pCS2-DLC1was transfected into the glioma cell line U251 and pCS2-MT was transfected as control group; Western blotting was employed to detect the DCL1 gene expression at the protein level: the expression of Myc; MTT assays were performed to assess the proliferation of glioma cell line U251. Results Glioma tissues showed a significant increased DCL1 gene expression at mRNA level as compared with the control brain tissues (P=0.000). The DLC1 gene expression at mRNA level in the Grade Ⅰ gliomas was obviously higher than that in Grade Ⅱ,Ⅲ or Ⅳ ones (P=0.001). Over-expression of Myc in pCS2-DLC1 transfected group was found, while no obvious Myc expression was noted in the control group. The pCS2-DLC1 transfected group showed higher proliferation level of U251 cell lines than the pCS2-MT control group (P=0.002). Conclusion High expression level of DLC1 might contribute to the formation and development of glioma.